Back

Validation of a Modified CHA2DS2-VASc score for stroke risk Stratification in Asian patients with qtrial fibrillation

30 August 2016 (10:05 - 10:15)
Organised by:
Congress Presentation Part of: Antithrombotic therapy in atrial fibrillation 2 Atrial fibrillation (AF) ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Tze-Fan Chao

Taipei Veterans General Hospital, Taipei (Taiwan)

4 More presentations in this session

Presentation thumbnail
Temporal change of anticoagulation therapy and its outcomes of Japanese atrial fibrillation patients in the real-world clinical practice: the Fushimi AF Registry.
Doctor M. Akao (Kyoto, JP)
Abstract Slides
Presentation thumbnail
Hospitalization-related costs among patients with atrial fibrillation treated with the factor Xa inhibitor edoxaban vs warfarin: results from the ENGAGE AF-TIMI 48 trial
Professor E. Magnuson (Kansas City, US)
Abstract Slides
Presentation thumbnail
Vitamin K antagonist control for patients with nonvalvular atrial fibrillation in Eastern and Southeastern Asia: an analysis of event rates from GARFIELD-AF
Professor S. Goto (Isehara, JP)
Abstract Slides
Presentation thumbnail
Reversal strategies and outcomes of major bleeding associated with direct oral anticoagulants compared to warfarin in routine practice: interim results from a multi-centre all-comer cohort
Mr Y. Xu (Toronto, CA)
Abstract Slides

Access the full session

Session thumbnail
Antithrombotic therapy in atrial fibrillation 2

The Event

Event poster

ESC Congress 2016

30 August 2016 10:05 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources